Status:
COMPLETED
Gastric Tolerability and Pharmacokinetics of DMMET-01
Lead Sponsor:
Laboratorios Silanes S.A. de C.V.
Conditions:
Healthy
Eligibility:
All Genders
18-35 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the gastric tolerability and the pharmacokinetics of a new drug for the treatment of type 2 diabetes, DMMET-01, in healthy volunteers.
Eligibility Criteria
Inclusion
- Mexican healthy subjects with normal clinical laboratory test results and imaging (hematology, blood chemistry, urine test, VDRL, Hepatitis B, HIV, chest radiography and electrocardiogram)
Exclusion
- Familiar or personal history of diabetes
- History of drug or alcohol abuse within the 2 years prior to the study
- A smoking habit greater tha 10 cigarettes per day
- Intercurrent disease
- Intercurrent treatment with any drug
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00960882
Start Date
June 1 2007
End Date
April 1 2008
Last Update
January 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pharmacology and toxicology department, UANL
Monterrey, Nuevo León, Mexico, 64460